NEW YORK (GenomeWeb News) – Fluidigm and NanoString Technologies have settled lawsuits filed by Fluidigm that accused NanoString of false advertising, unfair competition, and unlawful trade practice, the companies announced after the close of the market on Tuesday.

As part of the settlement, NanoString is required to remove all references to a single-cell comparison study of Fluidigm's and NanoString's single-cell products, and to recall and destroy all materials related to and/or based on the study, Fluidigm said.

Financial terms of the settlement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.